Abstract:Aims/hypothesis Insulin resistance is concomitant with metabolic syndrome, oxidative stress and cardiac contractile dysfunction. However, the causal relationship between oxidative stress and cardiac dysfunction is unknown. This study was designed to determine the impact of overexpression of the cardiac antioxidant metallothionein on cardiac dysfunction induced by insulin resistance in mice. Methods Whole-body insulin resistance was generated in wild-type FVB and metallothionein transgenic mice by feeding them with sucrose for 12 weeks. Contractile and intracellular Ca 2+ properties were evaluated in ventricular myocytes using an IonOptix system. The contractile indices analysed included: peak shortening (PS), time to 90% PS (TPS 90 ), time to 90% relengthening (TR 90 ), half-width duration, maximal velocity of shortening (+d L /d t ) and relengthening (−d L /d t ), fura-fluorescence intensity change (ΔFFI) and decay rate ( τ ). Results The sucrose-fed mice displayed glucose intolerance, enhanced oxidative stress, hyperinsulinaemia, hypertriglyceridaemia and normal body weight. Compared with myocytes in starch-fed mice, those from sucrose-fed mice exhibited depressed PS, +d L /d t , −d L /d t , prolonged TR 90 and decay rate, and reduced ΔFFI associated with normal TPS 90 and half-width duration. Western blot analysis revealed enhanced basal, but blunted insulin (15 mU/g)-stimulated Akt phosphorylation. It also showed elevated expression of insulin receptor β, insulin receptor tyrosine phosphorylation, peroxisome proliferator-activated receptor γ, protein tyrosine phosphatase 1B and phosphorylation of the transcription factor c- Jun , associated with a reduced fold increase of insulin-stimulated insulin receptor tyrosine phosphorylation in sucrose-fed mice. All western blot findings may be attenuated or ablated by metallothionein. Conclusions/interpretation These data indicate that oxidative stress may play an important role in cardiac contractile dysfunction associated with glucose intolerance and possibly related to alteration in insulin signalling at the receptor and post-receptor levels.

Metallothionein Prevents Diabetes-Induced Deficits in Cardiomyocytes by Inhibiting Reactive Oxygen Species Production.

Metallothionein Alleviates Cardiac Dysfunction in Streptozotocin-Induced Diabetes: Role of Ca2+ Cycling Proteins, NADPH Oxidase, Poly(adp-Ribose) Polymerase and Myosin Heavy Chain Isozyme

Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury.

Metallothionein as an Adaptive Protein Prevents Diabetes and its Toxicity

Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.

Activation of HIF-1 by Metallothionein Contributes to Cardiac Protection in the Diabetic Heart.

Metallothionein rescues hypoxia-inducible factor-1 transcriptional activity in cardiomyocytes under diabetic conditions.

Hypoxia‐inducible Factor 1α is Critically Involved in Metallothionein Protection Against Diabetic Cardiomyopathy

Metallothionein Antagonizes Aging-Induced Cardiac Contractile Dysfunction: Role of Ptp1b, Insulin Receptor Tyrosine Phosphorylation and Akt

Inhibition Of Superoxide Generation And Associated Nitrosative Damage Is Involved In Metallothionein Prevention Of Diabetic Cardiomyopathy

Endothelial Overexpression of Metallothionein Prevents Diabetes Mellitus-Induced Impairment in Ischemia Angiogenesis Via Preservation of HIF-1α/SDF-1/VEGF Signaling in Endothelial Progenitor Cells

Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2-knockout mice

The Adaptive Immune Role Of Metallothioneins In The Pathogenesis Of Diabetic Cardiomyopathy: Good Or Bad

Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis.

Abstract 13631: Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species With Mito-tempo Reduces Diabetic Cardiomyopathy

Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.

Metallothionein Alleviates Glutathione Depletion-Induced Oxidative Cardiomyopathy in Murine Hearts

Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling.

Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARγ and c- Jun

Diabetic cardiomyopathy and potential intervention

Role of Oxidative Stress in Diabetic Cardiomyopathy